Conversely, silencing Filamin A enhanced the metastatic ability of ICC cells, which could be reversed by silencing HSPB8 or BAG3 as well (Figure 5(c,d)). This evidence concerns the gene HSPB8 and intrahepatic cholangiocarcinoma.